Maria Cecilia Bahit

Causes of death and rehospitalization in patients hospitalized with worsening heart failure and reduced left ventricular ejection fraction: Results from efficacy of vasopressin antagonism in heart failure outcome study with tolvaptan (EVEREST) program

Christopher M. O’Connor, Alan B. Miller, John E. Blair et al. · American Heart Journal · 2010 · 235 citations

Medicine, Cardiology, Pharmacotherapy +11

Lipoprotein(a) and Benefit of PCSK9 Inhibition in Patients With Nominally Controlled LDL Cholesterol

Gregory G. Schwartz, Vera A. Bittner, Patricio López‐Jaramillo et al. · Journal of the American College of Cardiology · 2021 · 141 citations · Full text

Medicine, Cardiology, Pharmacology +17

Heart Failure Complicating Non–ST-Segment Elevation Acute Coronary Syndrome

Maria Cecilia Bahit, Renato D. Lópes, Robert M. Clare et al. · JACC Heart Failure · 2013 · 73 citations

Medicine, Cardiology, Internal Medicine +10

Relation of Lipoprotein(a) Levels to Incident Type 2 Diabetes and Modification by Alirocumab Treatment

Gregory G. Schwartz, Michael Szarek, Vera Bittner et al. · Diabetes Care · 2021 · 38 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17

Effect of Vericiguat on Left Ventricular Structure and Function in Patients with Heart Failure with Reduced Ejection Fraction: The VICTORIA Echocardiographic Substudy

Burkert Pieske, Elisabeth Pieske‐Kraigher, Carolyn S.P. Lam et al. · European Journal of Heart Failure · 2023 · 37 citations · Full text

Medicine, Cardiology, Pharmacotherapy +15